Should You Dump Sports Direct International Plc And Halfords Group plc And Buy GlaxoSmithKline plc?

Is it time for investors in Sports Direct International Plc (LON:SPD) and Halfords Group plc (LON:HFD) to consider a dose of GlaxoSmithKline plc (LON:GSK)?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I’m asking whether the shine has come off two former retail high flyers and whether it’s time to focus on a different sector of the market.

Sports Direct, elusive growth

Shares in Sports Direct International (LSE: SPD) have continued to slide this morning after yesterday’s disappointing results. The sports retailer’s shares are now down by 30% from their 52-week high of 820p.

Sales growth during the first half of this year was below expectations. The firm’s underlying pre-tax profit of £166.4m was lower than expected and analysts now seem likely to cut their full-year profit forecasts.

In my view, shareholders face a dilemma. Sports Direct doesn’t pay a dividend, so investors have to rely on the firm’s share price rising to generate returns. The shares are now worth 23% less than two years ago and have fallen by 30% since August.

Will founder Mike Ashley pull something out of the hat to reignite the firm’s growth? Perhaps he will, but because he controls Sports Direct so closely, investors have little way of knowing what might happen.

Personally, it’s not a risk I’d choose to take, especially given the allegations made in the press this week about the firm’s employment and pricing practices.

Halfords, shares to get cheaper?

Shares in car parts and bicycle seller Halfords Group (LSE: HFD) have fallen by 38% from the 52-week high of 562p seen in August.

Like Sports Direct, Halfords’ most recent interim results were below expectations. Like-for-like sales growth of just 1.7% was down from 7% for the same period last year and was less than the 3% expected by City analysts.

However, there are some bright spots. Halfords’ free cash flow remains strong and should comfortably cover this year’s forecast 17p dividend. This gives a prospective yield of 4.9%. The firm’s shares now trade on just 10 times forecast earnings, suggesting that they’re becoming quite cheap.

For shareholders, I think Halfords is more attractive than Sports Direct. I wouldn’t sell, but I’m not sure I’d rush to buy today either. If Halfords has a quiet Christmas then the shares could get much cheaper and become a genuine bargain.

Why buy Glaxo instead?

Halfords and Sports Direct have both delivered strong growth over the last few years, but both firms appear to be entering a period of slower growth.

One firm that could be moving in the opposite direction is GlaxoSmithKline (LSE: GSK). Shares in the UK’s biggest pharmaceutical firm have fallen by around 20% over the last two years due to a period of weak earnings.

However, Glaxo’s recent multi-part deal with Novartis has strengthened and expanded the firm’s portfolio in key growth areas such as vaccines and consumer health. The deal also helped fund a $4bn reduction in net debt to $10.5bn. That’s the lowest level since 2011.

City brokers now believe that Glaxo is poised for a period of growth. Earnings per share are expected to rise by 16% to 76p for 2015 and then by a further 10% to 84p in 2016.

Glaxo shares offer a 6% prospective yield and are currently trading close to their 52-week low. I rate Glaxo as a good long term buy.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline and Sports Direct International. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
Investing Articles

How I’d invest my first £20k ISA to target £4,900 a year from dividend shares

Looking for dividend shares in a new Stocks and Shares ISA, and want diversification too? Here's how I'd go about…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »